Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rebecca R Vanderpool

Showing results (31-40 of 50) with videos related to

Pageof 5
Sort By:
American Journal of Respiratory Cell and Molecular Biology|January 25, 2017
Development of a Mouse Model of Metabolic Syndrome, Pulmonary Hypertension, and Heart Failure with Preserved Ejection FractionQingqing Meng, Yen-Chun Lai, Neil J Kelly, et al.
American Journal of Physiology. Lung Cellular and Molecular Physiology|September 26, 2019
MicroRNA-mediated downregulation of K<sup>+</sup> channels in pulmonary arterial hypertensionAleksandra Babicheva, Ramon J Ayon, Tengteng Zhao, et al.
American Journal of Respiratory Cell and Molecular Biology|January 14, 2017
Mouse Genome-Wide Association Study of Preclinical Group II Pulmonary Hypertension Identifies Epidermal Growth Factor ReceptorNeil J Kelly, Josiah E Radder, Jeffrey J Baust, et al.
Pulmonary Circulation|December 21, 2020
Transcriptomic profiles in pulmonary arterial hypertension associate with disease severity and identify novel candidate genesCasey E Romanoski, Xinshuai Qi, Shreya Sangam, et al.
The American Journal of Medicine|February 9, 2018
Diabetes Mellitus Associates with Increased Right Ventricular Afterload and Remodeling in Pulmonary Arterial HypertensionMorgan E Whitaker, Vineet Nair, Shripad Sinari, et al.
American Journal of Physiology. Lung Cellular and Molecular Physiology|January 19, 2022
Mineralocorticoid receptor antagonist treatment of established pulmonary arterial hypertension improves interventricular dependence in the SU5416-hypoxia rat modelMengyun Lu, Li-Yuan Chen, Salina Gairhe, et al.
Circulation. Heart Failure|February 25, 2020
Comprehensive Diagnostic Evaluation of Cardiovascular Physiology in Patients With Pulmonary Vascular Disease: Insights From the PVDOMICS ProgramW H Wilson Tang, Jennifer D Wilcox, Miriam S Jacob, et al.
American Journal of Respiratory Cell and Molecular Biology|December 22, 2017
Nitric Oxide-Independent Soluble Guanylate Cyclase Activation Improves Vascular Function and Cardiac Remodeling in Sickle Cell DiseaseKarin P Potoka, Katherine C Wood, Jeffrey J Baust, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|April 10, 2020
Treatment With Treprostinil and Metformin Normalizes Hyperglycemia and Improves Cardiac Function in Pulmonary Hypertension Associated With Heart Failure With Preserved Ejection FractionLongfei Wang, Gunner Halliday, Joshua R Huot, et al.
British Journal of Pharmacology|January 25, 2020
Tetramethylpyrazine: A promising drug for the treatment of pulmonary hypertensionYuqin Chen, Wenju Lu, Kai Yang, et al.
Pageof 5

Showing results (31-40 of 50) with videos related to

Sort By:
Pageof 5
American Journal of Respiratory Cell and Molecular Biology|January 25, 2017
Development of a Mouse Model of Metabolic Syndrome, Pulmonary Hypertension, and Heart Failure with Preserved Ejection FractionQingqing Meng, Yen-Chun Lai, Neil J Kelly, et al.
American Journal of Physiology. Lung Cellular and Molecular Physiology|September 26, 2019
MicroRNA-mediated downregulation of K<sup>+</sup> channels in pulmonary arterial hypertensionAleksandra Babicheva, Ramon J Ayon, Tengteng Zhao, et al.
American Journal of Respiratory Cell and Molecular Biology|January 14, 2017
Mouse Genome-Wide Association Study of Preclinical Group II Pulmonary Hypertension Identifies Epidermal Growth Factor ReceptorNeil J Kelly, Josiah E Radder, Jeffrey J Baust, et al.
Pulmonary Circulation|December 21, 2020
Transcriptomic profiles in pulmonary arterial hypertension associate with disease severity and identify novel candidate genesCasey E Romanoski, Xinshuai Qi, Shreya Sangam, et al.
The American Journal of Medicine|February 9, 2018
Diabetes Mellitus Associates with Increased Right Ventricular Afterload and Remodeling in Pulmonary Arterial HypertensionMorgan E Whitaker, Vineet Nair, Shripad Sinari, et al.
American Journal of Physiology. Lung Cellular and Molecular Physiology|January 19, 2022
Mineralocorticoid receptor antagonist treatment of established pulmonary arterial hypertension improves interventricular dependence in the SU5416-hypoxia rat modelMengyun Lu, Li-Yuan Chen, Salina Gairhe, et al.
Circulation. Heart Failure|February 25, 2020
Comprehensive Diagnostic Evaluation of Cardiovascular Physiology in Patients With Pulmonary Vascular Disease: Insights From the PVDOMICS ProgramW H Wilson Tang, Jennifer D Wilcox, Miriam S Jacob, et al.
American Journal of Respiratory Cell and Molecular Biology|December 22, 2017
Nitric Oxide-Independent Soluble Guanylate Cyclase Activation Improves Vascular Function and Cardiac Remodeling in Sickle Cell DiseaseKarin P Potoka, Katherine C Wood, Jeffrey J Baust, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|April 10, 2020
Treatment With Treprostinil and Metformin Normalizes Hyperglycemia and Improves Cardiac Function in Pulmonary Hypertension Associated With Heart Failure With Preserved Ejection FractionLongfei Wang, Gunner Halliday, Joshua R Huot, et al.
British Journal of Pharmacology|January 25, 2020
Tetramethylpyrazine: A promising drug for the treatment of pulmonary hypertensionYuqin Chen, Wenju Lu, Kai Yang, et al.
Pageof 5